Fig. 3.
Fig. 3. Cyclin E-associated cdk2 in PMA-treated cells. (A) Cyclin E/cdk2 complexes are present in U937 cells during PMA-induced differentiation. Cells were treated with PMA for the indicated times and cyclin E immunoprecipitated from cell extract (1.4 mg total protein). An aliquot of the identical extract was also immunoprecipitated with cdk2 antibody. The immunoprecipitates were run on an SDS-PAGE, transferred to nitrocellulose, and on a Western blot probed with a cdk2 polyclonal antibody (1:3750 dilution). (B) PMA inhibits cyclin E-associated cdk2 activity. Cyclin E or cdk2 was immunoprecipitated from PMA-treated cell lysates (500 μg and 200 μg total protein, respectively) and analyzed for histone H1 activity as described in Materials and Methods.

Cyclin E-associated cdk2 in PMA-treated cells. (A) Cyclin E/cdk2 complexes are present in U937 cells during PMA-induced differentiation. Cells were treated with PMA for the indicated times and cyclin E immunoprecipitated from cell extract (1.4 mg total protein). An aliquot of the identical extract was also immunoprecipitated with cdk2 antibody. The immunoprecipitates were run on an SDS-PAGE, transferred to nitrocellulose, and on a Western blot probed with a cdk2 polyclonal antibody (1:3750 dilution). (B) PMA inhibits cyclin E-associated cdk2 activity. Cyclin E or cdk2 was immunoprecipitated from PMA-treated cell lysates (500 μg and 200 μg total protein, respectively) and analyzed for histone H1 activity as described in Materials and Methods.

Close Modal

or Create an Account

Close Modal
Close Modal